id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-E-0282-0010,FDA,FDA-1991-E-0282,Sankyo Co. Ltd. (Sanko) & Bristol-Myers - Amendment,Other,AMD-Amendment,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2013-07-27T21:30:13Z,,0,0,090000648052fa53
FDA-1991-E-0282-0001,FDA,FDA-1991-E-0282,Determination of Regulatory Review Period for Purposes of Patent Extension;Pravachol®;,Notice,N-Notice,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,1992-05-12T03:59:59Z,2009-05-14T21:35:13Z,,0,0,090000648052fa4a
FDA-1991-E-0282-0002,FDA,FDA-1991-E-0282,Determination of Regulatory Review Period for Pravachol®;Correction,Notice,NCR-Notice of Correction,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:14Z,,0,0,090000648052fa4b
FDA-1991-E-0282-0011,FDA,FDA-1991-E-0282,"FDA Response to Fox, Bennett & Turner - Letter",Other,ADV-Denial of Application,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:27Z,,0,0,090000648052fa54
FDA-1991-E-0282-0003,FDA,FDA-1991-E-0282,Determination of Regulatory Review Period for Pravachol®;Correction,Notice,NCR-Notice of Correction,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:16Z,,0,0,090000648052fa4e
FDA-1991-E-0282-0009,FDA,FDA-1991-E-0282,FDA Response to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:24Z,,0,0,090000648052fa4d
FDA-1991-E-0282-0006,FDA,FDA-1991-E-0282,FDA to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:20Z,,0,0,090000648052fa48
FDA-1991-E-0282-0005,FDA,FDA-1991-E-0282,"Sankyo Co., Ltd. - Patent Term Extension Application",Other,APP-Application,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:19Z,,0,0,090000648052fa45
FDA-1991-E-0282-0008,FDA,FDA-1991-E-0282,"Sankyo Co, Ltd.  and Bristol-Myers Squibb to FDA - Letter",Other,LET-Letter,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2013-07-27T21:30:13Z,,0,0,090000648052fa4c
FDA-1991-E-0282-0004,FDA,FDA-1991-E-0282,U.S. Patent and Trademark Office - Certificate Extending Patent,Rule,CEP-Certificate Extending Patent Term,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:17Z,,0,0,090000648052fa55
FDA-1991-E-0282-0007,FDA,FDA-1991-E-0282,"FDA Response to the Honorable Harry F. Manbeck, Jr. - Letter",Other,LET-Letter,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,,2009-05-14T21:35:22Z,,0,0,090000648052fa49